Stat News
STAT+: Medicare is spending far less than expected on new Alzheimer’s drugs

Adoption has been slow with new Alzheimer’s drugs because the treatments are complicated to administer and the benefits are uncertain.
S
Source
Stat News
Read full article at Stat News
Opens original article in a new tab
Advertisement



